Clinical Trial Update: A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of adding Zibotentan to Dapagliflozin versus Dapagliflozin alone in adults with chronic kidney disease and high proteinuri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Zibotentan (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease With High Proteinuria | Phase 2 | Status: RECRUITING